Nomura Holdings Inc Vertex Pharmaceuticals Inc Put Options Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $368,000 - $404,624	800 Added 2.42%	33,800 $15.7 Million
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $3.54 Million - $4.37 Million	9,000 Added 37.5%	33,000 $15.5 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $9.78 Million - $10.7 Million	24,000 New	24,000 $10 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $9.26 Million - $11.1 Million	27,000 New	27,000 $11 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $1.51 Million - $1.69 Million	4,800 New	4,800 $1.69 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.